Beyond Cultures: Biomarkers and Rapid Molecular Tests to Improve Antimicrobial Use
Back to course
Video Transcription
Video Summary
Asset Subtitle
Infection, Pharmacology, Quality and Patient Safety, 2022
Asset Caption
Increasing rates of antimicrobial drug resistance in the community and in the ICU imperil our ability to care for patients with sepsis and septic shock. In this session, we will review the clinical features that clinicians can use to guide rational antimicrobial drug use, new and emerging diagnostic tests that help us make the right choice of drugs more rapidly, and the data for novel antimicrobial agents, including beta-lactam/beta-lactamase inhibitors and tetracycline derivates, that may support the care of infected patients in the ICU.
Meta Tag
Content Type Presentation
Knowledge Area Infection
Knowledge Area Pharmacology
Knowledge Area Quality and Patient Safety
Knowledge Level Advanced
Membership Level Select
Tag Antibiotics
Tag Pharmacokinetics Pharmacodynamics
Tag Evidence Based Medicine
Year 2022
Keywords
rapid molecular tests
antimicrobial use
intensive care unit
antimicrobial drug resistance
timely administration
appropriate antibiotics